House to Vote on User Fee Reauthorization, Medical Device Tax Repeal Bills
Posted 29 May 2012 | By
The US House of Representatives is moving quickly to vote on a package of reforms and user fee proposals similar to one approved on 24 May by the US Senate, with House leadership confirming a bill containing the provisions will be brought to a vote on 30 May.
The bill, the Food and Drug Administration Reform Act (FDARA), would renew and expand user fee provisions required of industry and used to fund the US Food and Drug Administration (FDA), which would also see a number of reforms and program expansions under the legislation.
In a memo to members of the House Republican Caucus, Majority Leader Eric Cantor (R-VA) said members should expect FDARA to come to the chamber for a vote on Wednesday, 30 May.
Cantor's memo also hinted at an un-contentious markup process between the House and the Senate, saying the bill should be finished and ready for a final vote in both chambers of Congress in early July. "Though these programs expire at the end of September, the Energy and Commerce Committee hopes to complete negotiations with the Senate on a final bill by July 4th," wrote Cantor.
The House Energy and Commerce Committee, which has legislative jurisdiction over matters related to FDA, also released the final version of the legislation to be voted on by the House. The bill incorporates amendments to the bill made in a 9 May markup by the committee.
In a related development, Cantor said the House will take up an effort to repeal a medical device excise tax instituted under the Patient Protection and Affordable Care Act (PPACA), which Cantor called "draconian." A bill to repeal the tax, H.R. 436, is being sponsored by Minnesota Republican Erik Paulsen and is tentatively scheduled for the week of 4 July.
Cantor - Memo to House RepublicansBills to Be Considered in the House the Week of 28 May